Dorota Skowronska-Krawczyk

Dorota Skowronska-Krawczyk has extensive experience in the field of vision and neurodegenerative eye conditions. Dorota currently works as an Assistant Professor at the University of California, Irvine - College of Medicine, where their research focuses on understanding the impact of natural aging on vision and neurodegenerative eye conditions. Dorota uses molecular, biochemical, and cellular methods to decipher the processes affected by aging.

Prior to this, they worked as a Scientific Co-Founder at Visgenx, Inc in 2019. At Visgenx, they co-invented technology and intellectual property related to developing therapeutics for dry age-related macular degeneration.

Dorota also has a significant tenure at the University of California, San Diego - School of Medicine, where they held various positions including Assistant Professor, Associate Project Scientist, and Assistant Project Scientist. Dorota'swork at the university involved investigating molecular mechanisms related to anterior pituitary development and understanding the function of homeodomain superfamily transcription factors in establishing cell-type specific nuclear architecture.

Dorota'searlier experience includes working as a postdoctoral fellow at Eye Hospital Jules Gonin, where they contributed to research in the field of eye health. Dorota also worked as a PhD student at the University of Geneva, where their research focused on the molecular basis of retina development and the role of protein domains in cell fate determination and differentiation.

Overall, Dorota Skowronska-Krawczyk has a strong background in researching eye health and molecular mechanisms related to vision and neurodegenerative conditions.

Dorota Skowronska-Krawczyk pursued their education in a chronological order. Dorota began their academic journey at the University of Warsaw from 1993 to 1998, where they obtained a Bachelor's degree in Biology. Following this, they went on to pursue a PhD in Biochemistry from the University of Geneva, starting in 1998 and completing their studies in 2004.